LENSAR, Inc. (NASDAQ:LNSR) Sees Large Growth in Short Interest

LENSAR, Inc. (NASDAQ:LNSRGet Free Report) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 105,100 shares, an increase of 66.0% from the February 13th total of 63,300 shares. Based on an average daily volume of 93,700 shares, the days-to-cover ratio is currently 1.1 days. Currently, 1.2% of the shares of the company are short sold.

LENSAR Trading Up 3.6 %

LNSR stock traded up $0.53 on Friday, hitting $15.13. The company’s stock had a trading volume of 130,806 shares, compared to its average volume of 112,453. The firm has a 50 day moving average of $10.72 and a two-hundred day moving average of $7.78. LENSAR has a 1 year low of $2.67 and a 1 year high of $16.40. The stock has a market cap of $178.37 million, a price-to-earnings ratio of -10.36 and a beta of 0.62.

LENSAR (NASDAQ:LNSRGet Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($1.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($1.40). The firm had revenue of $16.73 million during the quarter, compared to analyst estimates of $14.95 million. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital upped their price target on shares of LENSAR from $12.00 to $16.00 and gave the company a “buy” rating in a research report on Friday, February 28th.

Read Our Latest Report on LENSAR

Hedge Funds Weigh In On LENSAR

Institutional investors have recently bought and sold shares of the company. Evernest Financial Advisors LLC acquired a new position in LENSAR in the 4th quarter valued at $174,000. Bailard Inc. acquired a new position in shares of LENSAR during the 4th quarter worth $181,000. Atria Investments Inc grew its stake in shares of LENSAR by 28.2% during the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company’s stock worth $233,000 after purchasing an additional 5,729 shares during the period. Essex Investment Management Co. LLC grew its stake in shares of LENSAR by 18.3% during the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company’s stock worth $357,000 after purchasing an additional 6,184 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of LENSAR by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company’s stock worth $460,000 after purchasing an additional 3,423 shares during the period. 40.15% of the stock is owned by institutional investors and hedge funds.

LENSAR Company Profile

(Get Free Report)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Featured Articles

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.